Cardiovascular complications in inflammatory bowel disease. - Test2 - elhamkhani - TriplyDB

Cardiovascular complications in inflammatory bowel disease.

Cardiovascular complications in inflammatory bowel disease.

http://www.wikidata.org/entity/Q35197222

about

Systematic review and meta-analysis of lactose digestion, its impact on intolerance and nutritional effects of dairy food restriction in inflammatory bowel diseases Influence of diet on the gut microbiome and implications for human health.Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular co-morbidities.Subclinical Atherosclerosis in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?Management of Cardiovascular Risk in Patients with Chronic Inflammatory Diseases: Current Evidence and Future Perspectives.Development of Inflammatory Bowel Disease Is Linked to a Longitudinal Restructuring of the Gut Metagenome in Mice.Inflammatory Bowel Disease and Risk of Ischemic Heart Disease: An Updated Meta-Analysis of Cohort Studies.

P2860

Q26740495-50BC5E40-FBFF-46A0-B82E-0794D2545E86 Q37742351-35BFC92F-F694-49E1-A69E-631ECA58F975 Q38603046-D8BC2E6C-FED0-4448-B57C-ECA6B98F3AC9 Q38851079-74DF982D-A216-41C5-9159-14924DC9B910 Q38918638-ECBD841D-F05D-441A-B926-BD098E80399A Q38972344-B79F5873-92DB-4774-9C62-27F3D3220F4D Q40041978-EC8FB919-E187-4337-A726-B06839610380 Q41628272-9D7BFDA2-E7B0-44AC-B78B-443175164615

P2860

Cardiovascular complications in inflammatory bowel disease.

http://www.wikidata.org/entity/Q35197222

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Cardiovascular complications in inflammatory bowel disease.

@ast

Cardiovascular complications in inflammatory bowel disease.

@en

type

label

Cardiovascular complications in inflammatory bowel disease.

@ast

Cardiovascular complications in inflammatory bowel disease.

@en

prefLabel

Cardiovascular complications in inflammatory bowel disease.

@ast

Cardiovascular complications in inflammatory bowel disease.

@en

P1433

Q35197222-1D9909FB-C99E-4480-BCDA-843E6972165A

P1476

Q35197222-8CC7AAE9-2A73-4B9F-9C84-FE9A769005DE

P2093

Q35197222-1CBE3ED5-28A3-4448-A023-71B3CF35790E

P2860

Q35197222-03EC249B-D175-4BB1-9490-E1FE7532F4C4

Q35197222-0D386166-8B85-4279-861A-DBAC2DCE1983

Q35197222-0EBE6972-9786-476B-8DAA-1400FDA38429

Q35197222-129AE316-77B6-459F-A201-086360AC7164

Q35197222-134AF45D-1E08-4601-ADB5-2EE2BAA294C5

Q35197222-162A605E-F5FE-471D-8549-B774E8FA9E81

Q35197222-1E627806-C7A7-4123-91B0-447DB713BEDC

Q35197222-2012F8C4-D900-416F-996C-5913BE3F66D9

Q35197222-233B368B-16AB-4707-874A-8E5764E69131

Q35197222-373766BA-9171-4E52-ADC2-D17E4F0F39B5

P304

Q35197222-3F28BBFA-CE91-4CF6-9969-9C5A3630C0E9

P31

Q35197222-99C76762-89B4-487E-B247-B0B2FAD6F209

P356

Q35197222-8D64FC32-7095-46D4-B2D5-E41744015C64

P433

Q35197222-1A69F2C0-C92A-4741-8B97-E50DB4FF15CF

P478

Q35197222-EB17F4BC-9FEA-461F-A7F1-99A11F78C38C

P50

Q35197222-AF2C7940-0401-4624-BE0D-A4A5E9ED067B

Q35197222-EB20BBE3-ED31-45B6-95B7-EDA46AF17A7D

P577

Q35197222-011958CB-321A-4D53-8F72-CFD176F30B01

P5875

Q35197222-52010003-7066-4792-8B75-AE2E3E53321B

P698

Q35197222-080C1056-382E-4FA2-92F9-6C65406E84D1

P921

Q35197222-6E0A6D3A-AE0C-401D-B004-22044F85E685

P932

Q35197222-41172500-C398-4A78-89A7-1ED7CD0D41B8

P356

1389450116666150202161500

P1433

Current Drug Targets

P1476

Cardiovascular complications in inflammatory bowel disease

@en

P2093

Martin Storr

http://www.w3.org/2001/XMLSchema#string

P2860

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

Reduction of atherosclerosis in mice by inhibition of CD40 signalling

Inflammation, atherosclerosis, and coronary artery disease

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Is there an association between inflammatory bowel diseases and carotid intima-media thickness? Preliminary data.

Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia

Expert consensus document on arterial stiffness: methodological issues and clinical applications.

Are patients with inflammatory bowel disease at increased risk of coronary artery disease?

Comparison of inflammation, arterial stiffness and traditional cardiovascular risk factors between rheumatoid arthritis and inflammatory bowel disease.

Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces.

P304

181-188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1389450116666150202161500

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Gunther Marsche

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271772487

http://www.w3.org/2001/XMLSchema#string

P698

25642719

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

4366573

http://www.w3.org/2001/XMLSchema#string